Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Implants & Prosthetics

Smith & Nephew Tandem Bipolar Hip Components Recalled for Oversized Retainer Ring

Agency Publication Date: November 7, 2024
Share:
Sign in to monitor this recall

Summary

Smith & Nephew, Inc. is recalling 21 units of its Tandem Bipolar Hip System component, specifically the Tandem International Bipolar Cocr Shell/UHMWPE Liner with a TI-6AL-4V Retaining Ring. The recall was initiated because the assembly contains an oversized retainer ring, which can interfere with the proper function of the hip replacement system. The affected devices were manufactured in the United States and distributed to hospitals and surgical centers internationally.

Risk

The oversized retainer ring can prevent the hip component from seating or assembling correctly during surgery. This could lead to surgical delays, the need for replacement components, or potential failure of the implant if the issue is not identified before or during the procedure. No injuries or incidents have been reported to date.

What You Should Do

  1. This recall involves the Smith & Nephew Tandem International Bipolar Cocr Shell/UHMWPE Liner (REF 71324046), specifically batch W2401399 with UDI-DI 03596010494375.
  2. Identify affected units by checking the reference and batch numbers printed on the sterile device packaging or hospital inventory records.
  3. Stop using the recalled device immediately and quarantine any remaining units in your inventory to ensure they are not used in surgical procedures.
  4. Contact Smith & Nephew, Inc. or your local distributor to arrange for the return, replacement, or correction of the affected components.
  5. Call the FDA Consumer Complaint hotline at 1-888-463-6332 for additional questions regarding medical device recalls.

Your Remedy Options

๐Ÿ“‹Other Action
How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Tandem Intl Bipolar Cocr Shell/UHMWPE Liner, TI-6AL-4V Retaining Ring, 28MM I.D. 46 MM O.D.
Variants: 28MM I.D. 46 MM O.D.
Model / REF:
71324046
Lot Numbers:
W2401399
UDI:
03596010494375

Sterile, femoral head bipolar component of the Tandem Bipolar Hip System.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 95568
Status: Active
Manufacturer: Smith & Nephew, Inc.
Sold By: Hospitals; Surgical Centers
Manufactured In: United States
Units Affected: 21 devices
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.